Maiwei Biology, Yingsi Intelligence, and Haoyuan Medicine have reached a strategic cooperation agreement.

Maiwei Biotechnology, Yingsi Intelligence, and Haoyuan Medicine officially announced today that they have reached a strategic cooperation agreement. The three parties will work together to create a new ADC compound library covering hundreds of targets, screen and promote the next generation of ADC candidate molecules, and accelerate the industrialization of innovative ADC drugs.